A/Prof David van der Poorten
Dr Roslyn Vongsuvanh
  Professor Golo Ahlenstiel
Dr Way Siow & Dr Rishi Sud
Email: admin@sydneynwgastro.com.au
Appointments & Enquiries:  (02) 8711 0160

Hepatitis C - new treatments now available!

hcv hepatitis c virus hepacivirus dengue infection flaviviridae flavovirus positive rna enveloped capsid virion

What is hepatitis C infection?

Hepatitis C is a blood borne infection of the liver caused by the hepatitis C virus. Over 70% of people infected will have long-lasting (chronic) inflammation of the liver. Approximately 220,000 people in Australia have hepatitis C.


How is hepatitis C virus spread? Am I at risk?

The hepatitis C virus is transmitted from the blood of an infected person to another. In Australia, the most common way hepatitis C is spread is through injecting drug use and sharing drug-injecting equipment.

You may be at risk of hepatitis C if you have the following risk factors:

  • injecting drug use
  • blood transfusion prior to 1991
  • tattoos and body piercing equipment that have not been properly sterilised
  • born in a country with high rates of hepatitis C- eg Egypt
  • needlestick injuries




Interferon-free treatment now available with Harvoni,      Sovaldi, Daklinza and Viekira Pak through SydneyNW Gastro!







What are the consequences of hepatitis C infection?

Up to 20% of people with chronic hepatitis C develop progressive scarring leading to cirrhosis. This may take up to 20 years to develop but can be accelerated with co-factors such as alcohol abuse, hepatitis B co-infection, obesity and diabetes. Patients with cirrhosis can have life-threatening complications such as liver failure and are at higher risk of liver cancer.


Can hepatitis C be treated?

There are treatments available for hepatitis C that may offer a chance of completely eradicating the virus. A number of factors influence the decision for therapy, including the type of hepatitis C virus, the extent of liver damage and underlying medical history. Therapies for hepatitis C are in a period of major development and change with the new DAAs now available to all patients who have active/chronic infection. Access to such therapies are available only by approved prescribers. Our specialists are approved prescribers and are in contact with a multidisciplinary team of nurses and trial co-ordinators at Westmead Hospital. Please have a discussion with our specialists today to see whether you may be eligible.


Specialised Services Provided

  • Assessment of hepatitis C disease stage and need for treatment
  • Fibroscan to assess extent of liver scarring (fibrosis)
  • Treatment of Hepatitis C with new direct acting antivirals (DAAs) such as Sovaldi (Sofosbuvir), Harvoni (Sofosbuvir/Ledipasvir), Daklinza (Daclatisvir) and Viekira Pak.
  • Liver cancer screening in patients with Hepatitis C

Research Articles

DVD hepC cannabis